Warning letter
Cipher Pharmaceuticals US LLC: warning letter of Aug 24, 2017
FDA warning letter 460380 · The Office of Prescription Drug Promotion (OPDP)
Key facts
| Reference number | 460380 |
|---|---|
| Company | Cipher Pharmaceuticals US LLC |
| Subject | False & Misleading Claims/Misbranded |
| Issue date | Aug 24, 2017 |
| Posted date | Aug 29, 2017 |
| Issuing office | The Office of Prescription Drug Promotion (OPDP) |
| Product type | Drugs |
| CFR sections cited | 202.1 |
| Country | 3 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: